151 related articles for article (PubMed ID: 17201146)
21. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
[TBL] [Abstract][Full Text] [Related]
22. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers.
Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
Oral Dis; 2011 Nov; 17(8):794-800. PubMed ID: 21819494
[TBL] [Abstract][Full Text] [Related]
23. Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray.
So K; Tamura G; Honda T; Homma N; Endoh M; Togawa N; Nishizuka S; Motoyama T
Pathol Int; 2006 Oct; 56(10):571-5. PubMed ID: 16984612
[TBL] [Abstract][Full Text] [Related]
24. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis.
Tonomoto Y; Tachibana M; Dhar DK; Onoda T; Hata K; Ohnuma H; Tanaka T; Nagasue N
Oncology; 2007; 73(5-6):346-56. PubMed ID: 18500170
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
[TBL] [Abstract][Full Text] [Related]
27. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.
Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D
Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036
[TBL] [Abstract][Full Text] [Related]
28. Frequent inactivation of RUNX3 in endometrial carcinoma.
Yoshizaki T; Enomoto T; Fujita M; Ueda Y; Miyatake T; Fujiwara K; Miyake T; Kimura T; Yoshino K; Kimura T
Gynecol Oncol; 2008 Sep; 110(3):439-44. PubMed ID: 18572225
[TBL] [Abstract][Full Text] [Related]
29. High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients.
Wong TS; Chang HW; Tang KC; Wei WI; Kwong DL; Sham JS; Yuen AP; Kwong YL
Clin Cancer Res; 2002 Feb; 8(2):433-7. PubMed ID: 11839660
[TBL] [Abstract][Full Text] [Related]
30. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
31. [Promoter methylation profile in gastric cancer].
Roa JC; Anabalón L; Roa I; Tapia O; Melo A; Villaseca M; Araya JC
Rev Med Chil; 2005 Aug; 133(8):874-80. PubMed ID: 16163424
[TBL] [Abstract][Full Text] [Related]
32. [Expression, loss of heterozygosity, and methylation of GNAT1 gene in nasopharyngeal carcinoma].
Yi HM; Ren CP; Peng D; Zhou L; Li H; Yao KT
Ai Zheng; 2007 Jan; 26(1):9-14. PubMed ID: 17222360
[TBL] [Abstract][Full Text] [Related]
33. Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.
Jarmalaite S; Jankevicius F; Kurgonaite K; Suziedelis K; Mutanen P; Husgafvel-Pursiainen K
Oncology; 2008; 75(3-4):145-51. PubMed ID: 18824877
[TBL] [Abstract][Full Text] [Related]
34. RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis.
Subramaniam MM; Chan JY; Soong R; Ito K; Yeoh KG; Wong R; Guenther T; Will O; Chen CL; Kumarasinghe MP; Ito Y; Salto-Tellez M
Am J Gastroenterol; 2009 Feb; 104(2):426-36. PubMed ID: 19174785
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer.
Kitajima Y; Ohtaka K; Mitsuno M; Tanaka M; Sato S; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jan; 19(1):197-202. PubMed ID: 18097595
[TBL] [Abstract][Full Text] [Related]
36. Promoter hypermethylation of Ras-related GTPase gene RRAD inactivates a tumor suppressor function in nasopharyngeal carcinoma.
Mo Y; Midorikawa K; Zhang Z; Zhou X; Ma N; Huang G; Hiraku Y; Oikawa S; Murata M
Cancer Lett; 2012 Oct; 323(2):147-54. PubMed ID: 22487779
[TBL] [Abstract][Full Text] [Related]
37. Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors.
Costa VL; Henrique R; Ribeiro FR; Pinto M; Oliveira J; Lobo F; Teixeira MR; Jerónimo C
BMC Cancer; 2007 Jul; 7():133. PubMed ID: 17645803
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients.
Richiardi L; Fiano V; Vizzini L; De Marco L; Delsedime L; Akre O; Tos AG; Merletti F
J Clin Oncol; 2009 Jul; 27(19):3161-8. PubMed ID: 19470943
[TBL] [Abstract][Full Text] [Related]
39. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
40. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
Han YX; Liang DY
Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]